Cure of ventriculitis and central nervous system shunt infection by Staphylococcus epidermidis with vancomycin by intraventricular injection in a liver transplant recipient

Transplant Infectious Disease

Volumn 9, Issue 1, 2007, Pages 46-50

  Schwabe, M ^a   Juttner E ^a   Blaich, A ^a   Potthoff, K ^a   Pisarski, P ^a   Waller, C F ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Central nervous system infection; Coagulase negative staphylococci; Intraventricular injection; Orthotopic liver transplantation; Vancomycin; Wilson's disease

Indexed keywords

CYCLOSPORIN A; MYCOPHENOLIC ACID; PREDNISONE; VANCOMYCIN;

ADULT; ARTICLE; BRAIN VENTRICULITIS; CASE REPORT; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID; FEMALE; HUMAN; LIVER FAILURE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MENINGOENCEPHALITIS; PRIORITY JOURNAL; STAPHYLOCOCCUS EPIDERMIDIS; VENTRICULOATRIAL SHUNT; WILSON DISEASE;

ADULT; ANTI-BACTERIAL AGENTS; CENTRAL NERVOUS SYSTEM FUNGAL INFECTIONS; CEREBROSPINAL FLUID SHUNTS; FEMALE; GRAFT REJECTION; HEPATOLENTICULAR DEGENERATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAVENOUS; INJECTIONS, INTRAVENTRICULAR; LIVER TRANSPLANTATION; MENINGITIS, FUNGAL; POSTOPERATIVE COMPLICATIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS; TIME FACTORS; TREATMENT OUTCOME; VANCOMYCIN;

EID: 33846944680     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2006.00157.x     Document Type: Article

References (27)

1. Ferenci P. Pathophysiology and clinical features of Wilson disease. Metab Brain Dis 2004; 19; 229-239.
2. Ala A, Schilsky ML. Wilson disease: pathophysiology, diagnosis, treatment, and screening. Clin Liver Dis 2004; 8: 787-805.
3. Gow PJ, Smallwood RA, Angus PW, Smith AL, Wall AJ, Sewell RB. Diagnosis of Wilson's disease: an experience over three decades. Gut 2000; 46: 415-419.
4. Durand F, Bernuau J, Giostra E, et al. Wilson's disease with severe hepatic insufficiency: beneficial effects of early administration of D-penicillamine. Gut 2001; 48: 849-852.
5. Schiodt FV, Atillasoy E, Shakil AO, et al. Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transpl Surg 1999; 5: 29-34.
6. Eghtesad B, Nezakatgoo N, Geraci LC, et al. Liver transplantation for Wilson's disease: a single-center experience. Liver Transpl Surg 1999; 5: 467-474.
7. Emre S, Atillasoy EO, Ozdemir S, et al. Orthotopic liver transplantation for Wilson's disease: a single-center experience. Transplantation 2001; 72: 1232-1236.
8. Geissler I, Heinemann K, Rohm S, Hauss J, Lamesch P. Liver transplantation for hepatic and neurological Wilson's disease. Transplant Proc 2003; 35: 1445-1446.
9. Sutcliffe RP, Maguire DD, Muiesan P, et al. Liver transplantation for Wilson's disease: long-term results and quality-of-life assessment. Transplantation 2003; 75: 1003-1006.
10. Rahman T, Hodgson H. Clinical management of acute hepatic failure. Intensive Care Med 2001; 27: 467-476.
11. Schwabe M, Zhao J, Kung HF. Differential expression and ligand-induced modulation of the human interleukin-6 receptor on interleukin-6-responsive cells. J Biol Chem 1994; 269: 7201-7209.
12. Wade JJ, Rolando N, Hayllar K, Philpott-Howard J, Casewell MW, Williams R. Bacterial and fungal infections after liver transplantation: an analysis of 284 patients. Hepatology 1995; 21: 1328-1336.
13. Whitehead WE, Kestle JR. The treatment of cerebrospinal fluid shunt infections. Results from a practice survey of the American society of pediatric neurosurgeons. Pediatr Neurosurg 2001; 35: 205-210.
14. Peters G, Locci R, Pulverer G. Adherence and growth of coagulase-negative staphylococci on surfaces of intravenous catheters. J Infect Dis 1982; 146: 479-482.
15. von Eiff C, Peters G, Heilmann C. Pathogenesis of infections due to coagulase-negative staphylococci. Lancet Infect Dis 2002; 2: 677-685.
16. Luer MS, Hatton J. Vancomycin administration into the cerebrospinal fluid: a review. Ann Pharmacother 1993; 27: 912-921.
17. Bayston R, Hart CA, Barnicoat M. Intraventricular vancomycin in the treatment of ventriculitis associated with cerebrospinal fluid shunting and drainage. J Neurol Neurosurg Psychiatry 1987; 50: 1419-1423.
18. Pfausler B, Spiss H, Beer R, et al. Treatment of staphylococcal ventriculitis associated with external cerebrospinal fluid drains: a prospective randomized trial of intravenous compared with intraventricular vancomycin therapy. J Neurosurg 2003; 98: 1040-1044.
19. Dhawan A, Taylor RM, Cheeseman P, De Silva P, Katsiyiannakis L, Mieli-Vergani G. Wilson's disease in children: 37-year experience and revised King's score for liver transplantation. Liver Transpl 2005; 11: 441-448.
20. Sen S, Felldin M, Steiner C, et al. Albumin dialysis and Molecular Adsorbents Recirculating System (MARS) for acute Wilson's disease. Liver Transpl 2002; 8: 962-967.
21. Wysocki M, Delatour F, Faurisson F, et al. Continuous versus intermittent infusion of vancomycin in severe Staphylococcal infections: prospective multicenter randomized study. Antimicrob Agents Chemother 2001; 45: 2460-2467.
22. Vuagnat A, Stern R, Lotthe A, et al. High dose vancomycin for osteomyelitis: continuous vs. intermittent infusion. J Clin Pharm Ther 2004; 29: 351-357.
23. Albanese J, Leone M, Bruguerolle B, Ayem ML, Lacarelle B, Martin C. Cerebrospinal fluid penetration and pharmacokinetics of vancomycin administered by continuous infusion to mechanically ventilated patients in an intensive care unit. Antimicrob Agents Chemother 2000; 44: 1356-1358.
24. Paya CV. Prevention of fungal and hepatitis virus infections in liver transplantation. Clin Infect Dis 2001; 33 (Suppl 1): S47-S52.
25. Huebner J, Goldmann DA. Coagulase-negative staphylococci: role as pathogens. Annu Rev Med 1999; 50: 223-236.
26. Lutsar I, McCracken GH Jr, Friedland IR. Antibiotic pharmacodynamics in cerebrospinal fluid. Clin Infect Dis 1998; 27: 1117-1127.
27. Di Filippo A, De Gaudio AR, Novelli A, et al. Continuous infusion of vancomycin in methicillin-resistant staphylococcus infection. Chemotherapy 1998; 44: 63-68.